Cancer Cause and Prevention Research in Virginia
Cancer Cause and Prevention Research (93.393) awarded $50.3 million to recipients in Virginia in 49 grants from fiscal 2021 to 2025, 1.4% of the program's national total. Rector & Visitors of the University of Virginia received the most, $22.9 million.
- Awarded in Virginia$50.3 million
- Awards49
- Share of the program1.4%
- Rank among states22nd of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 22 | $9.4 million |
| FY 2022 | 23 | $9.1 million |
| FY 2023 | 25 | $9.0 million |
| FY 2024 | 26 | $9.3 million |
| FY 2025 | 20 | $13.4 million |
Recipients in Virginia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rector & Visitors of the University of Virginia | Colleges and universities | 18 | $22.9 million |
| Virginia Commonwealth University | Colleges and universities | 21 | $17.1 million |
| Virginia Polytechnic Institute & State University | Colleges and universities | 2 | $2.9 million |
| Old Dominion University | Colleges and universities | 2 | $2.2 million |
| Isa Associates, Inc. | Small businesses | 1 | $1.7 million |
| American Indian Higher Education Consortium | Nonprofits | 1 | $1.2 million |
| Carina Medical LLC | Small businesses | 1 | $1.0 million |
| Arcascope Inc. | Small businesses | 1 | $739,378 |
| Benten Technologies, Inc. | Small businesses | 1 | $300,618 |
| American College of Radiology | Nonprofits | 1 | $137,306 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Virginia?
$50.3 million from fiscal 2021 to 2025, across 49 awards. Virginia ranks 22nd of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Virginia?
The largest recipient is Rector & Visitors of the University of Virginia, with $22.9 million in 18 awards. Next are Virginia Commonwealth University and Virginia Polytechnic Institute & State University.
Can organizations in Virginia apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Virginia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Emergency Food and Shelter National Board Program